Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
Abstract Advances in bladder cancer (BCa) treatment have been hampered by the lack of predictive biomarkers and targeted therapies. Here, we demonstrate that loss of the tumor suppressor NUMB promotes aggressive bladder tumorigenesis and worsens disease outcomes. Retrospective cohort studies show th...
Saved in:
| Main Authors: | F. A. Tucci, R. Pennisi, D. C. Rigiracciolo, M. G. Filippone, R. Bonfanti, F. Romeo, S. Freddi, E. Guerrera, C. Soriani, S. Rodighiero, R. H. Gunby, G. Jodice, F. Sanguedolce, G. Renne, N. Fusco, P. P. Di Fiore, G. Pruneri, G. Bertalot, G. Musi, G. Vago, D. Tosoni, S. Pece |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54246-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The CRL7FBXW8 Complex Controls the Mammary Stem Cell Compartment through Regulation of NUMB Levels
by: Simone Sabbioni, et al.
Published: (2025-07-01) -
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
by: Daniela Tosoni, et al.
Published: (2017-03-01) -
Architecture and Environmental Numbness
by: Sara Rahmani
Published: (2015-09-01) -
Numb and NumbL inhibit melanoma tumor growth by influencing the immune microenvironment
by: Siyu Zhang, et al.
Published: (2024-11-01) -
Female with left‐sided numbness and weakness
by: Shane C. Gately, et al.
Published: (2022-04-01)